Clinical Trial Categories

Esophageal Trials

« Return to Trial Main

Trial ID 20171

NCT03748134
clinicaltrials.gov ID
USOR ID: 20171 Phase III
ORIENT-15: A Multicenter, Double-Blind, Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Sintilimab vs. Placebo, in Combination with Chemotherapy, for First-Line Treatment of Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma
Trial Details
« Return to Trial Main

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology